The Medicare Prescription Drug Inflation Rebate Program will lower coinsurance for Medicare Part B beneficiaries for certain drugs, with savings between $2 and $390 per average dose starting April 1.

Medtronic acquired the technology in a 2022 deal reportedly worth $925 million.

Recent survey findings underscore that the vast majority of physicians believe prior authorization has a negative impact on patient care. In fact, some specialists think it leads to worse outcomes.

In years past, concerns have been raised over whether a growing radiation oncology workforce would eventually outpace patient demands, but a new report brings positive news.

The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

For the first time, Medicare will have the ability to negotiate prices of certain medications. These negotiations will focus on key questions such as the drug's benefits, the extent to which it fulfills an unmet medical need and its impact on Medicare beneficiaries.

Meanwhile, MedPAC has recommended a pay hike for physicians, drawing praise from the American Medical Association. 

Less than 10% of news articles published during a 12-year period mentioned the specialty and its role in LCS, experts wrote in AJR.